Beyond N staging in colorectal cancer: Current approaches and future perspectives

Traditionally, lymph node metastases (LNM) evaluation is essential to the staging of colon cancer patients according to the TNM (tumor–node–metastasis) system. However, in recent years evidence has accumulated regarding the role of emerging pathological features, which could significantly impact the...

Full description

Bibliographic Details
Main Authors: Gianluca Arrichiello, Mario Pirozzi, Bianca Arianna Facchini, Sergio Facchini, Fernando Paragliola, Valeria Nacca, Antonella Nicastro, Maria Anna Canciello, Adele Orlando, Marianna Caterino, Davide Ciardiello, Carminia Maria Della Corte, Morena Fasano, Stefania Napolitano, Teresa Troiani, Fortunato Ciardiello, Giulia Martini, Erika Martinelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.937114/full
_version_ 1828404043755552768
author Gianluca Arrichiello
Mario Pirozzi
Bianca Arianna Facchini
Sergio Facchini
Fernando Paragliola
Valeria Nacca
Antonella Nicastro
Maria Anna Canciello
Adele Orlando
Marianna Caterino
Davide Ciardiello
Carminia Maria Della Corte
Morena Fasano
Stefania Napolitano
Teresa Troiani
Fortunato Ciardiello
Giulia Martini
Erika Martinelli
author_facet Gianluca Arrichiello
Mario Pirozzi
Bianca Arianna Facchini
Sergio Facchini
Fernando Paragliola
Valeria Nacca
Antonella Nicastro
Maria Anna Canciello
Adele Orlando
Marianna Caterino
Davide Ciardiello
Carminia Maria Della Corte
Morena Fasano
Stefania Napolitano
Teresa Troiani
Fortunato Ciardiello
Giulia Martini
Erika Martinelli
author_sort Gianluca Arrichiello
collection DOAJ
description Traditionally, lymph node metastases (LNM) evaluation is essential to the staging of colon cancer patients according to the TNM (tumor–node–metastasis) system. However, in recent years evidence has accumulated regarding the role of emerging pathological features, which could significantly impact the prognosis of colorectal cancer patients. Lymph Node Ratio (LNR) and Log Odds of Positive Lymph Nodes (LODDS) have been shown to predict patients’ prognosis more accurately than traditional nodal staging and it has been suggested that their implementation in existing classification could help stratify further patients with overlapping TNM stage. Tumor deposits (TD) are currently factored within the N1c category of the TNM classification in the absence of lymph node metastases. However, studies have shown that presence of TDs can affect patients’ survival regardless of LNM. Moreover, evidence suggest that presence of TDs should not be evaluated as dichotomic but rather as a quantitative variable. Extranodal extension (ENE) has been shown to correlate with presence of other adverse prognostic features and to impact survival of colorectal cancer patients. In this review we will describe current staging systems and prognostic/predictive factors in colorectal cancer and elaborate on available evidence supporting the implementation of LNR/LODDS, TDs and ENE evaluation in existing classification to improve prognosis estimation and patient selection for adjuvant treatment.
first_indexed 2024-12-10T10:29:20Z
format Article
id doaj.art-c635368b544c4641a416a5d44b16752a
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-10T10:29:20Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-c635368b544c4641a416a5d44b16752a2022-12-22T01:52:38ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-07-011210.3389/fonc.2022.937114937114Beyond N staging in colorectal cancer: Current approaches and future perspectivesGianluca Arrichiello0Mario Pirozzi1Bianca Arianna Facchini2Sergio Facchini3Fernando Paragliola4Valeria Nacca5Antonella Nicastro6Maria Anna Canciello7Adele Orlando8Marianna Caterino9Davide Ciardiello10Carminia Maria Della Corte11Morena Fasano12Stefania Napolitano13Teresa Troiani14Fortunato Ciardiello15Giulia Martini16Erika Martinelli17Oncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyOncology Unit, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, ItalyTraditionally, lymph node metastases (LNM) evaluation is essential to the staging of colon cancer patients according to the TNM (tumor–node–metastasis) system. However, in recent years evidence has accumulated regarding the role of emerging pathological features, which could significantly impact the prognosis of colorectal cancer patients. Lymph Node Ratio (LNR) and Log Odds of Positive Lymph Nodes (LODDS) have been shown to predict patients’ prognosis more accurately than traditional nodal staging and it has been suggested that their implementation in existing classification could help stratify further patients with overlapping TNM stage. Tumor deposits (TD) are currently factored within the N1c category of the TNM classification in the absence of lymph node metastases. However, studies have shown that presence of TDs can affect patients’ survival regardless of LNM. Moreover, evidence suggest that presence of TDs should not be evaluated as dichotomic but rather as a quantitative variable. Extranodal extension (ENE) has been shown to correlate with presence of other adverse prognostic features and to impact survival of colorectal cancer patients. In this review we will describe current staging systems and prognostic/predictive factors in colorectal cancer and elaborate on available evidence supporting the implementation of LNR/LODDS, TDs and ENE evaluation in existing classification to improve prognosis estimation and patient selection for adjuvant treatment.https://www.frontiersin.org/articles/10.3389/fonc.2022.937114/fullcolorectal cancertumor staginglymph node metastasesadjuvant treatmentTNM
spellingShingle Gianluca Arrichiello
Mario Pirozzi
Bianca Arianna Facchini
Sergio Facchini
Fernando Paragliola
Valeria Nacca
Antonella Nicastro
Maria Anna Canciello
Adele Orlando
Marianna Caterino
Davide Ciardiello
Carminia Maria Della Corte
Morena Fasano
Stefania Napolitano
Teresa Troiani
Fortunato Ciardiello
Giulia Martini
Erika Martinelli
Beyond N staging in colorectal cancer: Current approaches and future perspectives
Frontiers in Oncology
colorectal cancer
tumor staging
lymph node metastases
adjuvant treatment
TNM
title Beyond N staging in colorectal cancer: Current approaches and future perspectives
title_full Beyond N staging in colorectal cancer: Current approaches and future perspectives
title_fullStr Beyond N staging in colorectal cancer: Current approaches and future perspectives
title_full_unstemmed Beyond N staging in colorectal cancer: Current approaches and future perspectives
title_short Beyond N staging in colorectal cancer: Current approaches and future perspectives
title_sort beyond n staging in colorectal cancer current approaches and future perspectives
topic colorectal cancer
tumor staging
lymph node metastases
adjuvant treatment
TNM
url https://www.frontiersin.org/articles/10.3389/fonc.2022.937114/full
work_keys_str_mv AT gianlucaarrichiello beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT mariopirozzi beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT biancaariannafacchini beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT sergiofacchini beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT fernandoparagliola beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT valerianacca beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT antonellanicastro beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT mariaannacanciello beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT adeleorlando beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT mariannacaterino beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT davideciardiello beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT carminiamariadellacorte beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT morenafasano beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT stefanianapolitano beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT teresatroiani beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT fortunatociardiello beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT giuliamartini beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives
AT erikamartinelli beyondnstagingincolorectalcancercurrentapproachesandfutureperspectives